Curis Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 5.93 Cr
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 12.33 Cr
About Curis Lifesciences
Curis Lifesciences Limited (CLL) is a Public Limited Indian Non-Government Company incorporated in India on 23 March 2016 (Eight years and 11 months 7 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 5.93 Cr.
The company currently has active open charges totaling ₹12.33 Cr.
The Key Managerial Personnel (KMP) at Curis Lifesciences Limited India are Pragnesh Sharma as CFO and Nikhil Purohit as Company Secretary. Jaimik Patel, Dharmesh Patel, Siddhant Pawasia, and Four other members serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230GJ2016PLC086559
- Company No.
086559
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Mar 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Chemicals
Who are the key members and board of directors at Curis Lifesciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharmesh Patel  | Managing Director | 23-Mar-2016 | Current |
| Pragnesh Sharma | CFO | 11-Nov-2024 | Current |
| Nikhil Purohit | Company Secretary | 11-Nov-2024 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Piyush Antala | Whole-Time Director | 23-Mar-2016 | Current |
| Jaimik Patel | Whole-Time Director | 23-Mar-2016 | Current |
| Siddhant Pawasia | Director | 23-Mar-2016 | Current |
| Chand Kanabar | Director | 06-Nov-2024 | Current |
| Grishma Shewale | Director | 06-Nov-2024 | Current |
| Shyam Kapadia | Director | 06-Nov-2024 | Current |
Financial Performance of Curis Lifesciences.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Curis Lifesciences?
Unlock access to Curis Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Shining Tools LimitedChand Kanabar, Grishma Shewale and 1 more are mutual person
Al-Sami Agro Products Private LimitedNikhil Purohit is a mutual person
- Golden Sparrow Consultancy Private Limited
Chand Kanabar is a mutual person
- Accretion Pharmaceuticals Limited
Grishma Shewale and Shyam Kapadia are mutual person
Charges (Loans)
Open Charges
₹12.33 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 12.33 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Apr 2023 | Others | ₹3.50 M | Open |
| 21 Mar 2017 | Others | ₹11.98 Cr | Open |
How Many Employees Work at Curis Lifesciences?
Unlock and access historical data on people associated with Curis Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Curis Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curis Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.